TABLE 2. COVID-19 signs, symptoms, and outcomes among attendees (N = 55) of an exercise facility — Chicago, Illinois, August 24–September 1, 2020.
| Signs, symptoms, and outcomes | No. (%)* |
|---|---|
|
Signs and symptoms
| |
| Headache |
38 (69.1) |
| Loss of taste or smell |
33 (60.0) |
| Myalgia |
33 (60.0) |
| Chills |
31 (56.4) |
| Cough |
28 (50.9) |
| Fever (measured or subjective) |
22 (40.0) |
| Shortness of breath |
22 (40.0) |
| Fatigue |
22 (40.0) |
| Sore throat |
13 (23.6) |
| Diarrhea† |
12 (21.8) |
| Rhinorrhea |
11 (20.0) |
| Nausea or vomiting |
10 (18.2) |
| Congestion |
8 (14.5) |
| Loss of appetite |
5 (9.1) |
| Abdominal pain |
5 (9.1) |
| Confusion |
2 (3.6) |
|
Outcomes
| |
| Emergency department visit |
2 (3.6) |
| Hospital admission§ |
1 (1.8) |
| Death | 0 (—) |
Abbreviation: COVID-19 = coronavirus disease 2019.
* Signs, symptoms, and outcome data were unavailable for eight (14.5%) attendees with COVID-19 who were not interviewed.
† Three or more loose, or looser than normal, stools in 24 hours.
§ One attendee with COVID-19 was hospitalized for 8 days, without use of oxygen, intubation, or ventilation.